Company news
Valirx Plc (LSE:VAL) news
Valirx Plc news releases on 6ix. Latest, Dec 6, 2022: Shareholder Communications and Investor Webinar
Press releases — page 3
Shareholder Communications and Investor Webinar
December 6, 2022
Quarterly Operational and Strategy Update
December 6, 2022
Subsidiary Launched and IP License Signed
October 24, 2022
Issue of Share Options
October 18, 2022
Director Appointment
October 11, 2022
Live Shareholder Q&A and industry events
September 22, 2022
Appointment of Interim Chief Scientific Officer
September 8, 2022
Shareholder Communications
August 17, 2022
Successful evaluation of breast cancer programme
July 13, 2022
Director/PDMR Shareholding
July 7, 2022
Broker Option Results
July 5, 2022
Result of AGM and Appointment of Joint Broker
June 30, 2022
Issue of Equity
June 30, 2022
Extends exclusivity period for TheoremRx
June 30, 2022
Update on VAL201 sub-license agreement
June 17, 2022
Annual Report, AGM Notice & Director Resignation
June 7, 2022
Operational and Strategy Update
March 15, 2022
Evaluation agreement with University of Barcelona
February 14, 2022
Signs Service Agreement with TheoremRx
January 5, 2022
Amends License for VAL201 with CRT
December 20, 2021
Evaluation agreement with Hokkaido University
December 16, 2021
Live Shareholder Q&A and Investor presentations
November 11, 2021
Signs Letter of Intent to Sub-License VAL201
November 2, 2021
New Evaluation Agreement
September 16, 2021
Appointment of Broker
August 25, 2021
Patent update
July 6, 2021
KTH222 Evaluation Agreement Concluded
May 27, 2021
Posting of Annual Report and Notice of AGM
April 30, 2021
Final Results
April 27, 2021
Total Voting Rights
March 1, 2021
Block listing Interim Review
February 25, 2021
Extension of Collaboration Agreement
February 15, 2021
Director Disclosure
January 19, 2021
VAL201 Clinical Trial Full Data Results
November 30, 2020
Agreement with Kalos Therapeutics
November 10, 2020
Total Voting Rights and Block Listing Update
November 2, 2020
Exercise of Warrant
October 2, 2020
VAL201 Clinical Trial Update
September 28, 2020
Share Price Movement / Exercise of Warrant
September 23, 2020
Exercise of Warrants and Warrant Update
September 14, 2020
Block Listing Application and Company Update
August 19, 2020
Broker Option - Fully Subscribed
July 24, 2020
Fundraise
July 23, 2020
AGM Arrangements
July 17, 2020
Corporate Update
July 6, 2020
Notice of AGM
July 1, 2020
Appointment of Director
June 29, 2020
New shareholder communication process
June 11, 2020
Correction Directorate Change & Audited accounts
June 8, 2020
Collaboration Agreement Signed
June 2, 2020